scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1035068060 |
P356 | DOI | 10.1038/NCHEMBIO.1361 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nchembio.1361 |
P932 | PMC publication ID | 3970981 |
P698 | PubMed publication ID | 24121552 |
P5875 | ResearchGate publication ID | 257754445 |
P2093 | author name string | Eric D Brown | |
Lauren F Ferruccio | |||
Soumaya Zlitni | |||
P2860 | cites work | Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 |
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America | Q24601746 | ||
Biotin synthesis begins by hijacking the fatty acid synthetic pathway | Q24629071 | ||
Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes | Q28238338 | ||
Target identification in chemical genetics: the (often) missing link | Q28262958 | ||
Metabolism and action of amino acid analog anti-cancer agents | Q28298599 | ||
Biosynthesis of 7, 8-diaminopelargonic acid from 7-keto-8-aminopelargonic acid and S-adenosyl-L-methionine. The kinetics of the reaction | Q28336637 | ||
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression | Q28477282 | ||
Drugs for bad bugs: confronting the challenges of antibacterial discovery | Q29547723 | ||
Nucleotide biosynthesis is critical for growth of bacteria in human blood | Q30841127 | ||
Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways | Q30885679 | ||
Existence of two D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymes | Q30909765 | ||
Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. | Q31070591 | ||
Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility | Q31121406 | ||
Large-scale identification of virulence genes from Streptococcus pneumoniae. | Q31968558 | ||
A comprehensive library of fluorescent transcriptional reporters for Escherichia coli | Q33251466 | ||
An integrated platform of genomic assays reveals small-molecule bioactivities | Q33351287 | ||
Functional genomics: expression analysis of Escherichia coli growing on minimal and rich media | Q33638195 | ||
Considerations when prescribing trimethoprim-sulfamethoxazole | Q34223201 | ||
Structural enzymology of biotin biosynthesis | Q34232138 | ||
Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo | Q34241048 | ||
The effect of amino acid analogues on growth and protein synthesis in microorganisms | Q35544195 | ||
Chemogenomic profiling: identifying the functional interactions of small molecules in yeast | Q35554300 | ||
Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis | Q35689501 | ||
Metabolism of 6-aminonicotinic acid in Escherichia coli | Q36603676 | ||
Mechanism of d -Cycloserine Action: Transport Systems for d -Alanine, d -Cycloserine, l -Alanine, and Glycine | Q36787670 | ||
Speculative strategies for new antibacterials: all roads should not lead to Rome | Q38101243 | ||
Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. | Q39569905 | ||
The behavior and significance of slow-binding enzyme inhibitors | Q39635194 | ||
Sulfonamides and folic acid antagonists: a historical review | Q39663235 | ||
Comparative action of glyphosate as a trigger of energy drain in eubacteria | Q39961774 | ||
Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures | Q40743914 | ||
Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthase | Q42212750 | ||
Is the GAIN Act a turning point in new antibiotic discovery? | Q42268705 | ||
Utilization of L-threnonine by a pseudomonad: a catabolic role for L-threonine aldolase | Q42934746 | ||
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. | Q43270534 | ||
The construction of systematic in-frame, single-gene knockout mutant collection in Escherichia coli K-12. | Q54424353 | ||
Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic | Q57805088 | ||
Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analogues | Q70939325 | ||
Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis | Q73909083 | ||
THE ENZYMATIC SYNTHESIS OF D-ALANYL-D-ALANINE. 3. ON THE INHIBITION OF D-ALANYL-D-ALANINE SYNTHETASE BY THE ANTIBIOTIC D-CYCLOSERINE | Q76900696 | ||
Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate | Q78868845 | ||
An agar plate assay for biotin | Q82351577 | ||
Metabolism of 6-aminonicotinic acid in Escherichia coli. | Q105009312 | ||
P433 | issue | 12 | |
P304 | page(s) | 796-804 | |
P577 | publication date | 2013-10-13 | |
P1433 | published in | Nature Chemical Biology | Q904026 |
P1476 | title | Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation | |
P478 | volume | 9 |
Q48241249 | 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase. |
Q89965407 | A Moraxella Virulence Factor Catalyzes an Essential Esterase Reaction of Biotin Biosynthesis |
Q96230670 | A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii |
Q38990080 | A robust platform for chemical genomics in bacterial systems. |
Q47804224 | Actinorhodin is a redox-active antibiotic with a complex mode of action against Gram-positive cells. |
Q36055552 | Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase |
Q38704810 | Antibacterial drug discovery in the resistance era. |
Q40163906 | Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy-d-xylulose 5-Phosphate Synthase. |
Q93074400 | Chemical-Chemical Combinations Map Uncharted Interactions in Escherichia coli under Nutrient Stress |
Q36277847 | Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis |
Q62673364 | Drug combinations: a strategy to extend the life of antibiotics in the 21st century |
Q46899589 | Drug discovery: Leaving no stone unturned |
Q91650255 | Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance |
Q30636019 | Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum |
Q33708635 | Expression and Activity of the BioH Esterase of Biotin Synthesis is Independent of Genome Context |
Q35661873 | Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA. |
Q55093817 | Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. |
Q58569022 | High-Throughput Screening of Biodiversity for Antibiotic Discovery |
Q53707434 | High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds. |
Q33653817 | Horizontally Acquired Biosynthesis Genes Boost Coxiella burnetii's Physiology |
Q27681548 | Inhibition ofMycobacterium tuberculosisTransaminase BioA by Aryl Hydrazines and Hydrazides |
Q49914281 | Integrated Metabolomics and Morphogenesis Reveals Volatile Signaling of the Nematode-Trapping Fungus Arthrobotrys oligospora. |
Q48175708 | Mechanistic Basis for ATP-Dependent Inhibition of Glutamine Synthetase by Tabtoxinine-β-lactam |
Q99550899 | Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections |
Q90317498 | Metabolic dependency of chorismate in Plasmodium falciparum suggests an alternative source for the ubiquinone biosynthesis precursor |
Q90975671 | Mimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogens |
Q54259390 | Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole. |
Q26799749 | Next-generation antimicrobials: from chemical biology to first-in-class drugs |
Q58549114 | Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli |
Q40189627 | Opportunities for natural products in 21st century antibiotic discovery |
Q41365032 | Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents |
Q91866694 | Revitalizing antifolates through understanding mechanisms that govern susceptibility and resistance |
Q27702218 | Selective small-molecule inhibition of an RNA structural element |
Q38710256 | Strategies for target identification of antimicrobial natural products |
Q30393244 | Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis |
Q37460655 | Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates |
Q39159676 | The Genome-Wide Interaction Network of Nutrient Stress Genes in Escherichia coli |
Q90675577 | The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in Staphylococcus aureus Dihydropteroate Synthase |
Q38534653 | Unconventional screening approaches for antibiotic discovery |
Q36730046 | Untargeted Metabolomics To Ascertain Antibiotic Modes of Action. |
Q55456503 | Vitamin Biosynthesis as an Antifungal Target. |
Search more.